How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

3,768 results for

Thromboembolic Disease in Pregnancy

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

141. Prediction of Recurrent Pregnancy Loss by a New Thrombophilia Based Genetic Risk Score

associated with thrombophilia could be more useful in the prediction for RPL than FVL and PT alone. Condition or disease Miscarriage, Recurrent Detailed Description: Recurrent pregnancy loss can affect up to 5% of women in child-bearing age and is considered one of the most common causes of female sterility. In recent years, the association between thrombophilia and pregnancy failure has been observed in a number of studies, varying according to the nature of the thrombophilia (for example (...) a higher risk of developing thromboembolism and complications in pregnancy. Another recent meta-analysis of prospective cohort studies concluded that women who were carriers of FVL had a higher risk of late pregnancy loss, at 52%, as opposed to non-carriers (OR=1.52), though the differences in absolute risk were discreet (4.2% and 3.2%, respectively). However, the analysis of these 2 single nucleotide polymorphisms (SNPs) showed low discriminative capacity and diagnostic sensitivity. This study

2017 Clinical Trials

142. Hypercapnic respiratory failure during pregnancy due to polymyositis-related respiratory muscle weakness: a case report (PubMed)

Hypercapnic respiratory failure during pregnancy due to polymyositis-related respiratory muscle weakness: a case report Polymyositis is a rare medical disorder complicating pregnancy. Ventilatory muscle weakness leading to respiratory failure is an uncommon manifestation of this autoimmune disease. We report a case of life-threatening hypercapnic respiratory failure due to polymyositis-related respiratory muscle weakness in a pregnant woman.A 31-year-old, African woman in her second trimester (...) of pregnancy presented to the emergency department with fever, shortness of breath and muscle weakness. Initial investigations excluded pulmonary infection, thromboembolism, and cardiac dysfunction as the underlying cause of her symptoms. She developed deterioration in her level of consciousness due to carbon dioxide narcosis requiring invasive mechanical ventilation. Further workup revealed markedly elevated serum creatine kinase, abnormal electromyography and edema of her thigh muscles on magnetic

Full Text available with Trip Pro

2017 Journal of medical case reports

143. Autoimmune hepatitis and pregnancy: report of two cases with different maternal outcomes (PubMed)

Autoimmune hepatitis and pregnancy: report of two cases with different maternal outcomes Women of childbearing age with autoimmune hepatitis (AIH) are now able to get pregnant. The progress of the disease during pregnancy is not well clarified yet. The first pregnant woman had cirrhosis secondary to AIH, and she delivered by cesarean section. The patient had severe thrombocytopenia at the time of hospitalization. Unfortunately, she died due to massive thromboembolism at the 24th hour after (...) delivery. The other patient had three recurrent abortions with a diagnosis of AIH. Low-dose low molecular weight heparin and low-dose acetylsalicylic acid along with low-dose prednisolone were administered during the course of the following pregnancies. The following pregnancies ended up with a living child. There is a high morbidity and mortality risk for both fetus and mother. Hepatic performance of the patients, thrombotic events, inflammatory disorders and autoimmune system activation must

Full Text available with Trip Pro

2017 Clinical and Experimental Hepatology

144. CRACKCast E087 – Peripheral Arteriovascular Disease

, MSK shoulder disease, peripheral neuropathies, MS, ETOH abuse, diabetes, and many others! Management depends on the severity and type: Nerve compression only = physio, shoulder rehab, then maybe surgery Arterial compression is a BIG deal: Risk for thrombosis, thromboembolism, acute ischemia, rupture, etc. Acute thrombosis = see the first few questions above. 17) List four anatomic abnormalities associated with thoracic outlet syndrome. See Rosen’s Fig 87-3. Think muscle, ligament, and bone (...) CRACKCast E087 – Peripheral Arteriovascular Disease CRACKCast E087 - Peripheral Arteriovascular Disease - CanadiEM CRACKCast E087 – Peripheral Arteriovascular Disease In , , by Chris Lipp June 26, 2017 This episode of CRACKCast covers Rosen’s Chapter 87, Peripheral Arteriovascular Disease. This episode covers the diagnosis and management of acute and chronic arterial insufficiency, differentiating between thrombotic and embolic insufficiency, as well as aneurysms, AV fistulae, and thoracic

2017 CandiEM

145. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

, Yao X, Shah ND, Gersh BJ? Comparative effective- ness and safety of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and valvular heart disease? Int J Cardiol? 2016;209:181–3? 36? Avezum A, Lopes RD, Schulte PJ, et al? Apixaban in comparison with warfarin in patients with atrial fibrillation and valvular heart disease: findings from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial (...) 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines CLINICAL STATEMENTS AND GUIDELINES Circulation. 2017;135:e1159–e1195. DOI: 10.1161/CIR.0000000000000503 June 20/27, 2017 e1159 WRITING GROUP MEMBERS* Rick A. Nishimura, MD, MACC, FAHA, Co-Chair Catherine M. Otto, MD, FACC, FAHA, Co-Chair Robert O. Bonow, MD, MACC

2017 American Heart Association

146. 2017 Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: A Joint Consensus Document from EHRA and ESC Working Group on Thrombosis

‘valvular AF’ and refer simply to ‘AF related to hemodynamically significant mitral stenosis or prosthetic mechanical heart valves’. AF clearly leads to an incremental risk for thromboembolism in patients with mitral valve stenosis, but there are limited data for other valvular diseases. Another proposal is to use the acronym MARM-AF as a simple acronym to designate ‘Mechanical and Rheumatic Mitral AF’ as an alternative to term ‘valvular AF’ to designate the clinical scenarios for which at the non (...) valves 3.5 High Lillehei-Kaster, Omniscience, Starr-Edwards, Bjork-Shiley and other tilting-disc valves 4.0 * Risk factors: previous thromboembolism; AF; mitral stenosis of any degree; left ventricular ejection fraction < 35%. Reproduced from reference. The duration of antithrombotic therapy also varies according to a number of factors. Lifelong anticoagulant treatment is indicated for all patients with mechanical valves and those with bioprosthetic valves or native valve disease with ≥1 additional

Full Text available with Trip Pro

2017 Heart Rhythm Society

147. Heart Disease and Stroke Statistics 2017 Update: A Report From the American Heart Association

Cardiac Arrest . . . . . . . . . . . . . . e468 19. Subclinical Atherosclerosis . . . . . . . . . . . . e487 20. Coronary Heart Disease, Acute Coronary Syndrome, and Angina Pectoris. . . . . . . . . . e505 21. Cardiomyopathy and Heart Failure . . . . . . . . e523 22. Valvular Diseases . . . . . . . . . . . . . . . . e539 23. Venous Thromboembolism (Deep Vein Thrombosis and Pulmonary Embolism), Chronic Venous Insufficiency, Pulmonary Hypertension. . . e548 24. Peripheral Artery Disease and Aortic (...) , which occurs among 1.0% to 8.8% of those with pulmo- nary embolism. • Assuming 375 000 to 425 000 new cases of venous thromboembolism annually, the overall cost of venous thromboembolism was estimated at $7 billion to $10 billion annually. New Section on Chronic Venous Insufficiency • Varicose veins affect 25 million US adults. More severe venous disease affects 6 million. • Venous ulcer is a substantial morbidity of chronic venous insufficiency. Estimated prevalence in adults is ˜0.3

Full Text available with Trip Pro

2017 American Heart Association

148. Self-Care for the Prevention and Management of Cardiovascular Disease and Stroke

Simple 7” (ie, smoking cessation, maintenance of body mass index [BMI], physical activity, healthy diet, maintaining low cholesterol, maintaining normal blood pressure [BP], and maintaining normal fasting plasma glucose). These behaviors have been shown to reduce incident stroke, HF, venous thromboembolism, and chronic kidney disease, and even incident cognitive impairment and non‐CVD. Self‐Care as a Decision‐Making Process Self‐care is most commonly understood as a naturalistic decision‐making (...) be addressed early. For example, pregnancy is considered a “natural stress test” that uncovers risk for future CVD among mothers. Women with hypertension or preeclampsia during pregnancy have more than double the risk for a future CVD or cerebrovascular disease death or diagnosis than women who do not have these conditions during pregnancy. LBW among offspring or delivery of a preterm baby place the mother at increased risk for CVD. Early self‐care during this window of opportunity could stave off

2017 American Heart Association

149. Pulmonary hypertensive vascular changes in lungs of patients with sudden unexpected death. Emphasis on congenital heart disease, Eisenmenger syndrome, postoperative deaths and death during pregnancy and postpartum. (PubMed)

Pulmonary hypertensive vascular changes in lungs of patients with sudden unexpected death. Emphasis on congenital heart disease, Eisenmenger syndrome, postoperative deaths and death during pregnancy and postpartum. Pulmonary hypertension (PH) in asymptomatic patients is a rare cause of sudden death. This study aims to determine the incidence of this entity and raise awareness among pathologists.We retrospectively investigated 44 cases of sudden unexpected death in relation to PH in patients (...) heart disease. The cause of PH was recognised as congenital heart disease in 27 patients (61.36%), 14 of whom had simple congenital heart disease, such as atrial or ventricular septal defect,and 13 had complex congenital heart disease with associated atrial septal defect or ventricular septal defect. The remaining 17 patients (29.55%) suffered from primary PH due to plexiform arteriopathy, veno-occlusive disease and thromboembolic disease. Extensive sampling of the lungs is required to detect

Full Text available with Trip Pro

2014 Journal of Clinical Pathology

150. Practice bulletin no. 123: thromboembolism in pregnancy. (PubMed)

, the leading cause of maternal death is hemorrhage (11); however, in developed nations, where hemorrhage is more often successfully treated and prevented, thromboembolic disease is one of the leading causes of death (12). The prevalence and severity of this condition during pregnancy and the peripartum period warrant special consideration of management and therapy. Such therapy includes the treatment of acute thrombotic events and prophylaxis for those at increased risk of thrombotic events. The purpose (...) Practice bulletin no. 123: thromboembolism in pregnancy. Pregnant women have a fourfold to fivefold increased risk of thromboembolism compared with nonpregnant women (1, 2). Approximately 80% of thromboembolic events in pregnancy are venous (3), with a prevalence of 0.5–2.0 per 1,000 pregnant women (4–9). Venous thromboembolism, including pulmonary embolism, accounts for 1.1 deaths per 100,000 deliveries (3), or 9 % of all maternal deaths in the United States (10). In the developing world

2011 Obstetrics and Gynecology

151. The Association of Coloproctology of Great Britain and Ireland Consensus Guidelines in Surgery for Inflammatory Bowel Disease

of indications, and including 9850 patients with IBD, the 30‐day incidence of venous thromboembolism was 3.1% in IBD patients. The 30‐day incidence of venous thromboembolism was noted to be higher in patients with ulcerative colitis than in patients with Crohn's disease (4.1% vs 2.1%, P < 0.001). Importantly, the cumulative incidence of venous thromboembolism increased from 1.3% at 7 days to 4.3% at 90 days after surgery in patients with IBD . Rates of postoperative venous thromboembolism are consistently (...) The Association of Coloproctology of Great Britain and Ireland Consensus Guidelines in Surgery for Inflammatory Bowel Disease The Association of Coloproctology of Great Britain and Ireland consensus guidelines in surgery for inflammatory bowel disease - Brown - 2018 - Colorectal Disease - Wiley Online Library By continuing to browse this site, you agree to its use of cookies as described in our . Search within Search term Search term The full text of this article hosted at iucr.org

Full Text available with Trip Pro

2018 Association of Coloproctology of Great Britain and Ireland

152. Pulmonary Disease and Pregnancy (Treatment)

and respiratory muscle function in pregnancy. Am Rev Respir Dis . 1991 Oct. 144(4):837-41. . Crapo RO. Normal cardiopulmonary physiology during pregnancy. Clin Obstet Gynecol . 1996 Mar. 39(1):3-16. . Cydulka RK, Emerman CL, Schreiber D, Molander KH, Woodruff PG, Camargo CA Jr. Acute asthma among pregnant women presenting to the emergency department. Am J Respir Crit Care Med . 1999 Sep. 160(3):887-92. . Douketis JD, Ginsberg JS. Diagnostic problems with venous thromboembolic disease in pregnancy. Haemostasis (...) . 1995 Jan-Apr. 25(1-2):58-71. . Elkus R, Popovich J Jr. Respiratory physiology in pregnancy. Clin Chest Med . 1992 Dec. 13(4):555-65. . Ginsberg JS, Hirsh J, Rainbow AJ, Coates G. Risks to the fetus of radiologic procedures used in the diagnosis of maternal venous thromboembolic disease. Thromb Haemost . 1989 Apr 25. 61(2):189-96. . King TE Jr. Restrictive lung disease in pregnancy. Clin Chest Med . 1992 Dec. 13(4):607-22. . Laibl VR, Sheffield JS. Influenza and pneumonia in pregnancy. Clin

2014 eMedicine.com

153. Pulmonary Disease and Pregnancy (Overview)

and respiratory muscle function in pregnancy. Am Rev Respir Dis . 1991 Oct. 144(4):837-41. . Crapo RO. Normal cardiopulmonary physiology during pregnancy. Clin Obstet Gynecol . 1996 Mar. 39(1):3-16. . Cydulka RK, Emerman CL, Schreiber D, Molander KH, Woodruff PG, Camargo CA Jr. Acute asthma among pregnant women presenting to the emergency department. Am J Respir Crit Care Med . 1999 Sep. 160(3):887-92. . Douketis JD, Ginsberg JS. Diagnostic problems with venous thromboembolic disease in pregnancy. Haemostasis (...) . 1995 Jan-Apr. 25(1-2):58-71. . Elkus R, Popovich J Jr. Respiratory physiology in pregnancy. Clin Chest Med . 1992 Dec. 13(4):555-65. . Ginsberg JS, Hirsh J, Rainbow AJ, Coates G. Risks to the fetus of radiologic procedures used in the diagnosis of maternal venous thromboembolic disease. Thromb Haemost . 1989 Apr 25. 61(2):189-96. . King TE Jr. Restrictive lung disease in pregnancy. Clin Chest Med . 1992 Dec. 13(4):607-22. . Laibl VR, Sheffield JS. Influenza and pneumonia in pregnancy. Clin

2014 eMedicine.com

154. Pulmonary Disease and Pregnancy (Follow-up)

and respiratory muscle function in pregnancy. Am Rev Respir Dis . 1991 Oct. 144(4):837-41. . Crapo RO. Normal cardiopulmonary physiology during pregnancy. Clin Obstet Gynecol . 1996 Mar. 39(1):3-16. . Cydulka RK, Emerman CL, Schreiber D, Molander KH, Woodruff PG, Camargo CA Jr. Acute asthma among pregnant women presenting to the emergency department. Am J Respir Crit Care Med . 1999 Sep. 160(3):887-92. . Douketis JD, Ginsberg JS. Diagnostic problems with venous thromboembolic disease in pregnancy. Haemostasis (...) . 1995 Jan-Apr. 25(1-2):58-71. . Elkus R, Popovich J Jr. Respiratory physiology in pregnancy. Clin Chest Med . 1992 Dec. 13(4):555-65. . Ginsberg JS, Hirsh J, Rainbow AJ, Coates G. Risks to the fetus of radiologic procedures used in the diagnosis of maternal venous thromboembolic disease. Thromb Haemost . 1989 Apr 25. 61(2):189-96. . King TE Jr. Restrictive lung disease in pregnancy. Clin Chest Med . 1992 Dec. 13(4):607-22. . Laibl VR, Sheffield JS. Influenza and pneumonia in pregnancy. Clin

2014 eMedicine.com

155. Pulmonary Disease and Pregnancy (Diagnosis)

and respiratory muscle function in pregnancy. Am Rev Respir Dis . 1991 Oct. 144(4):837-41. . Crapo RO. Normal cardiopulmonary physiology during pregnancy. Clin Obstet Gynecol . 1996 Mar. 39(1):3-16. . Cydulka RK, Emerman CL, Schreiber D, Molander KH, Woodruff PG, Camargo CA Jr. Acute asthma among pregnant women presenting to the emergency department. Am J Respir Crit Care Med . 1999 Sep. 160(3):887-92. . Douketis JD, Ginsberg JS. Diagnostic problems with venous thromboembolic disease in pregnancy. Haemostasis (...) . 1995 Jan-Apr. 25(1-2):58-71. . Elkus R, Popovich J Jr. Respiratory physiology in pregnancy. Clin Chest Med . 1992 Dec. 13(4):555-65. . Ginsberg JS, Hirsh J, Rainbow AJ, Coates G. Risks to the fetus of radiologic procedures used in the diagnosis of maternal venous thromboembolic disease. Thromb Haemost . 1989 Apr 25. 61(2):189-96. . King TE Jr. Restrictive lung disease in pregnancy. Clin Chest Med . 1992 Dec. 13(4):607-22. . Laibl VR, Sheffield JS. Influenza and pneumonia in pregnancy. Clin

2014 eMedicine.com

156. Recommendations for the diagnosis and treatment of deep venous thrombosis and pulmonary embolism in pregnancy and the postpartum period

diseases during pregnancy , European Heart Journal , 10.1093/eurheartj/ehy340 , 39 , 34 , (3165-3241) , (2018) . Roza Chaireti and Katarina Bremme , Risk Factors, Treatment and Prevention of Venous Thromboembolism During Pregnancy and Postpartum , Embolic Diseases - Unusual Therapies and Challenges , 10.5772/67709 , (2017) . Antonin Zoubian, Laurent Bertoletti and Paul Frappé , After deep vein thrombosis, which patients refer to vascular specialist for anticoagulant withdrawal? A Delphi study results (...) thrombosis and pulmonary embolism in pregnancy and the postpartum period National Women’s Health, Auckland City Hospital, Grafton, Auckland, New Zealand Department of Haematology, Prince of Wales Hospital, Sydney, New South Wales Clinical Haematology Department, Monash Medical Centre, Clayton Australian Centre for Blood Diseases, Monash University, Prahran, Victoria Discipline of Obstetrics and Gynaecology, University of Adelaide, Lyell McEwin Hospital Department of Obstetrics and Gynaecology, Women’s

2012 Clinical Practice Guidelines Portal

157. Prevention of Cardiovascular Disease in Women

, high volume hypertension than men. 289 Combined oral contraceptive (COC) use may cause a small but detectable increase in BP . 290 A small percentage of women develop frank hypertension. A family history of hypertension, pre-existing pregnancy-induced hypertension, occult renal disease, obesity, age > 35 years, COC dosage, composition and duration of use increase susceptibility to COC-induced hypertension. 290 This usually resolves within 3 months of the withdrawal of the COC. 291 COC induced (...) is 0.2, 1.3, and 2.2% per year for CHA 2 DS 2 -VASc scores of 0, 1, and 2 respectively. 497 Patients with a CHA 2 DS 2 -VASc score of 2 or more, should be considered for anticoagulation with: • warfarin or • NOAC 497 In those with a CHA 2 DS 2 -VASc score of 1, consideration for anticoagulant therapy should be individualized. 497,498 I, B I, A I, A I, B IIa, C86 2016 Patients who are 75 years 2 Diabetes Mellitus 1 Prior Stroke or TIA or thromboembolism 2 Vascular Disease 1 Age 64-74 years 1 Female

2016 Ministry of Health, Malaysia

158. Preventing and Experiencing Ischemic Heart Disease as a Woman: State of the Science

Preventing and Experiencing Ischemic Heart Disease as a Woman: State of the Science Preventing and Experiencing Ischemic Heart Disease as a Woman: State of the Science | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 March 2019 March 2019 March 2019 March 2019 February 2019 February 2019 February 2019 February 2019 January 2019 January 2019 January 2019 January 2019 January 2019 This site uses cookies. By continuing to browse this site (...) you are agreeing to our use of cookies. Free Access article Share on Jump to Free Access article Preventing and Experiencing Ischemic Heart Disease as a Woman: State of the Science A Scientific Statement From the American Heart Association , PhD, RN, FAHA, Chair , PhD, RN, FAHA, Vice Chair , PhD, RN, ACNS-BC , PhD, CNP, FAHA , PhD, MPH , MD, MSPH , MD , MD, MS, FAHA , MD, FAHA , and PhD, APRN, FAHA PhDon behalf of the American Heart Association Council on Cardiovascular and Stroke Nursing, Council

Full Text available with Trip Pro

2016 American Heart Association

159. Chronic Heart Failure in Congenital Heart Disease

Chronic Heart Failure in Congenital Heart Disease Chronic Heart Failure in Congenital Heart Disease | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search October 2019 September 2019 August 2019 July 2019 June 2019 May 2019 April 2019 March 2019 February 2019 January 2019 This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Free Access article Share on Jump to Free Access article Chronic Heart Failure (...) in Congenital Heart Disease A Scientific Statement From the American Heart Association , MD, Chair , MD, Co-Chair , MD , MD , MD , MD, MSc , MD , MD, PhD , , MD, FAHA , MD, FAHA , MD , MD , MD, FAHA , MD, MHSc , and MD MD, FAHAon behalf of the American Heart Association Council on Clinical Cardiology, Council on Functional Genomics and Translational Biology, and Council on Cardiovascular Radiology and Imaging Karen K. Stout , Craig S. Broberg , Wendy M. Book , Frank Cecchin , Jonathan M. Chen , Konstantinos

2016 American Heart Association

160. Evaluation of Suspected Pulmonary Embolism In Pregnancy: An Official ATS/STR Clinical Practice Guideline

–1999. MMWR Morb Mortal Wkly Rep 2003;52:1–8. 2. Marik PE, Plante LA. Venous thromboembolic disease and pregnancy. N Engl J Med 2008;359:2025–2033. 3. Royal College of Obstetricians and Gynaecologists. Green-top Guide- line No. 28: Thromboembolic Disease in Pregnancy and the Puerpe- rium: Acute Management. 2007 [accessed Oct. 4, 2011]. Available from: www.rcog.org.uk/guidelines 4. Stein PD, Woodard PK, Weg JG, Wake?eld TW, Tapson VF, Sostman HD, Sos TA, Quinn DA, Leeper KV Jr, Hull RD, et al (...) ). Accurate clinical diagnosis of venous thromboembolism (VTE) in pregnancy is notoriously dif- ?cult due to the overlap of signs and symptoms between physio- logic changes of pregnancy and development of PE or deep venousthrombosis(DVT)(2);VTEisultimatelycon?rmedinless than 10% of pregnant women who present with concerning clin- ical features (2). Although an array of diagnostic tests is currently available, clinicians confronted with management of a pregnant woman with suspected PE are often uncertain

2011 American Thoracic Society

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>